Sunrest Lifescience Rights Issue details are now available. The firm plans to issue 42,91,200 equity shares amounting to Rs 15.02 crores. Sunrest Lifescience Rights issue price is Rs 35 per share, and the face value is Rs 10 per share.
Sunrest Lifescience Rights Issue open date is April 2, 2026 and the close date is April 30, 2026. Sunrest Lifescience rights issue entitlement ratio is 1:1, which is 1 Rights Equity Shares for every 1 fully paid-up Equity Shares held on the record date.
Sunrest Lifescience Rights Issue record date is March 23, 2026. The last date to buy shares of Sunrest Lifescience is March 20, 2026. This rights Issue subscription status will be available soon.
Sunrest Lifescience Rights Issue allotment date, credit date and the listing date will be available soon. However, the listing will be on the NSE.
Sunrest Lifescience rights issue registrar and the book-running lead manager for this rights issue will be available soon.
Also Read | Supra Pacific Financial Services Rights Issue 2026 Details, Record Date
Sunrest Lifescience Rights Issue Details
Sunrest Lifescience Rights Issue details are as follows: the company plans to issue 42,91,200 equity shares, aggregating the amount of Rs 15.02 crores. Sunrest Lifescience Rights issue price is Rs 35 per share. The rights issue entitlement ratio is 1:1, which is 1 Rights Equity Shares for every 1 fully paid-up equity share(s).
|
Issue Open |
April 2, 2026 – April 30, 2026 |
|
Security Name |
Sunrest Lifescience Limited |
|
Issue Size (Shares) |
42,91,200 |
|
Issue Size (Amount) |
Rs 15.02 Crores |
|
Issue Price |
Rs 35 per share |
|
Face Value |
Rs 10 per share |
|
Listing At |
NSE |
|
Terms of Payment |
Rs 35 per share payable in full at the time of application |
|
Entitlement Ratio |
1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date |
Sunrest Lifescience Rights Issue Dates
Sunrest Lifescience Rights issue record date is March 23, 2026 and the last date to buy shares of Sunrest Lifescience is March 20, 2026.
|
Last Date to buy shares |
March 20, 2026 |
|
Record Date |
March 23, 2026 |
|
Credit of Rights Entitlements |
- |
|
Bid/Offer Opens On |
April 2, 2026 |
|
Renunciation of Rights Entitlements |
March 20, 2026 |
|
Bid/Offer Closes On |
April 30, 2026 |
|
Deemed Date of Allotment |
- |
|
Credit Date |
- |
|
Listing Date |
- |
Sunrest Lifescience Rights Issue Subscription
Sunrest Lifescience Rights Issue subscription status will be available after the issue goes live. The details of the Rights Issue entitlement are 1 Rights Equity Share(s) for every 1 fully paid-up Equity Share(s) held on the Record Date. Sunrest Lifescience issue price is Rs 35 per share.
Sunrest Lifescience Limited: About the Company
Sunrest Lifescience Limited stands as a pharmaceutical firm rooted in Ahmedabad, Gujarat, India, established on October 30, 2017. From its early days, the company has built a network spanning Gujarat, Maharashtra, and Rajasthan, connecting with over 250 distributors and 25,000 retailers through a dedicated team of 130 sales representatives. Founders Amit Thakkar, Nikhil Thakkar, Bharat Thakkar, and Bhagyesh Parekh guide its operations from the registered office at FF-41, Ajay Tenament-6, near Canal, Vastral Road.
The firm specializes in OTC brands for healthcare and personal care, offering more than 300 products like tablets, capsules, syrups, ointments, gels, powders, and toothpastes. Its range covers anti-bacterials, antibiotics, anti-fungals, analgesics, anti-hypertensives, anti-inflammatories, nutraceuticals, Ayurvedic remedies, and cosmetics, all aimed at everyday wellness needs. Sunrest Lifescience Limited emphasizes quality standards and strong marketing support for partners, fostering trust in a competitive industry.
Sunrest Lifescience Limited Financials (Amount in Rs crore)
|
Period Ended |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
58.65 |
25.16 |
16.71 |
|
Total Income |
33.42 |
29.48 |
24.67 |
|
Profit After Tax |
2.01 |
0.23 |
2.04 |
|
Reserves and Surplus |
12.02 |
9.89 |
0.11 |
Sunrest Lifescience Rights Issue Registrar
Sunrest Lifescience rights issue registrar and the book-running lead manager(s) for this rights issue will be available soon.
FAQs
1. What are the details of the Sunrest Lifescience Rights Issue?
Sunrest Lifescience Rights Issue details are as follows: Sunrest Lifescience plans to issue 42,91,200 equity shares amounting to Rs 15.02 crores. Sunrest Lifescience Rights issue price is Rs 35 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 1:1, which is 1 Rights Equity Share(s) for every 1 fully paid-up equity share(s).
2. Sunrest Lifescience Rights Issue open date and close date?
Sunrest Lifescience Rights Issue's open date is April 2, 2026, and the closing date is April 30, 2026. Sunrest Lifescience Rights Issue record date is March 23, 2026. The last date to buy shares of Sunrest Lifescience is March 20, 2026.
3. How can I apply for the Sunrest Lifescience Rights Issue?
You can apply for Sunrest Lifescience in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).
4. What is the entitlement ratio for the Sunrest Lifescience Rights Issue?
Sunrest Lifescience rights issue entitlement ratio is 1:1, which is 1 Rights Equity Share(s) for every 1 fully paid-up equity share(s).
5. How can I check the Sunrest Lifescience Issue Allotment Status?
The registrar for the Sunrest Lifescience rights issue registrar is not yet available, once its available investors can check the allotment status by visiting the registrar's website.
6. From where can I get the Sunrest Lifescience Rights Issue Letter of Offer?
You can download the Sunrest Lifescience Rights Issue Letter of Offer from here.
7. What is the listing date of the Sunrest Lifescience Rights Issue?
The Sunrest Lifescience Rights Issue listing date is not yet available. However, the listing will be on the NSE.
8. Who is the registrar and the lead manager of the Sunrest Lifescience Rights Issue?
Sunrest Lifescience rights issue registrar and the book-running lead manager(s) for this rights issue will be available soon.
Also Read | Maha Rashtra Apex Corporation Rights Issue 2026 Details, Record Date